0001737087-18-000001.txt : 20180411 0001737087-18-000001.hdr.sgml : 20180411 20180411102400 ACCESSION NUMBER: 0001737087-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180411 DATE AS OF CHANGE: 20180411 EFFECTIVENESS DATE: 20180411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dianomi Therapeutics, Inc. CENTRAL INDEX KEY: 0001737087 IRS NUMBER: 821336579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-309836 FILM NUMBER: 18749315 BUSINESS ADDRESS: STREET 1: 10071 BRISTLERIDGE STREET CITY: PARKER STATE: CO ZIP: 80134-8711 BUSINESS PHONE: 303-880-9590 MAIL ADDRESS: STREET 1: 10071 BRISTLERIDGE STREET CITY: PARKER STATE: CO ZIP: 80134-8711 D 1 primary_doc.xml X0708 D LIVE 0001737087 Dianomi Therapeutics, Inc. 10071 BRISTLERIDGE STREET PARKER CO COLORADO 80134-8711 303-880-9590 DELAWARE None None Corporation true 2017 Barry Kurokawa 10071 Bristleridge Street Parker CO COLORADO 80134-8711 Executive Officer Director William Murphy 10071 Bristleridge Street Parker CO COLORADO 80134-8711 Executive Officer Director Carter Cliff 10071 Bristleridge Street Parker CO COLORADO 80134-8711 Executive Officer Director Kurtis Knapp 10071 Bristleridge Street Parker CO COLORADO 80134-8711 Executive Officer Director Biotechnology No Revenues 06b false 2018-03-30 false true false 100000 2000000 185000 1815000 false 5 0 0 0 true The Company shall use the proceeds from the transactions contemplated hereby as working capital for product development and other general corporate purposes. The executive officers may receive compensation from the Issuer's investment proceeds. false Dianomi Therapeutics, Inc. Barry Kurokawa Barry Kurokawa Chief Executive Officer 2018-04-10